Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey. Josling, P. Advances in Therapy, 18(4):189–193, August, 2001. doi abstract bibtex One hundred forty-six volunteers were randomized to receive a placebo or an allicin-containing garlic supplement, one capsule daily, over a 12-week period between November and February. They used a five-point scale to assess their health and recorded any common cold infections and symptoms in a daily diary. The active-treatment group had significantly fewer colds than the placebo group (24 vs 65, P \textless .001). The placebo group, in contrast, recorded significantly more days challenged virally (366 vs 111, P \textless .05) and a significantly longer duration of symptoms (5.01 vs 1.52 days, P \textless .001). Consequently, volunteers in the active group were less likely to get a cold and recovered faster if infected. Volunteers taking placebo were much more likely to get more than one cold over the treatment period. An allicin-containing supplement can prevent attack by the common cold virus.
@article{josling_preventing_2001,
title = {Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey},
volume = {18},
issn = {0741-238X},
shorttitle = {Preventing the common cold with a garlic supplement},
doi = {10.1007/BF02850113},
abstract = {One hundred forty-six volunteers were randomized to receive a placebo or an allicin-containing garlic supplement, one capsule daily, over a 12-week period between November and February. They used a five-point scale to assess their health and recorded any common cold infections and symptoms in a daily diary. The active-treatment group had significantly fewer colds than the placebo group (24 vs 65, P {\textless} .001). The placebo group, in contrast, recorded significantly more days challenged virally (366 vs 111, P {\textless} .05) and a significantly longer duration of symptoms (5.01 vs 1.52 days, P {\textless} .001). Consequently, volunteers in the active group were less likely to get a cold and recovered faster if infected. Volunteers taking placebo were much more likely to get more than one cold over the treatment period. An allicin-containing supplement can prevent attack by the common cold virus.},
language = {eng},
number = {4},
journal = {Advances in Therapy},
author = {Josling, P.},
month = aug,
year = {2001},
pmid = {11697022},
keywords = {Adult, Aged, Anti-Infective Agents, Common Cold, Dietary Supplements, Female, Garlic, Humans, Male, Middle Aged, Probability, Reference Values, Sulfinic Acids, Treatment Outcome},
pages = {189--193},
}
Downloads: 0
{"_id":"3FbxyF3fjWnq9nZYD","bibbaseid":"josling-preventingthecommoncoldwithagarlicsupplementadoubleblindplacebocontrolledsurvey-2001","author_short":["Josling, P."],"bibdata":{"bibtype":"article","type":"article","title":"Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey","volume":"18","issn":"0741-238X","shorttitle":"Preventing the common cold with a garlic supplement","doi":"10.1007/BF02850113","abstract":"One hundred forty-six volunteers were randomized to receive a placebo or an allicin-containing garlic supplement, one capsule daily, over a 12-week period between November and February. They used a five-point scale to assess their health and recorded any common cold infections and symptoms in a daily diary. The active-treatment group had significantly fewer colds than the placebo group (24 vs 65, P \\textless .001). The placebo group, in contrast, recorded significantly more days challenged virally (366 vs 111, P \\textless .05) and a significantly longer duration of symptoms (5.01 vs 1.52 days, P \\textless .001). Consequently, volunteers in the active group were less likely to get a cold and recovered faster if infected. Volunteers taking placebo were much more likely to get more than one cold over the treatment period. An allicin-containing supplement can prevent attack by the common cold virus.","language":"eng","number":"4","journal":"Advances in Therapy","author":[{"propositions":[],"lastnames":["Josling"],"firstnames":["P."],"suffixes":[]}],"month":"August","year":"2001","pmid":"11697022","keywords":"Adult, Aged, Anti-Infective Agents, Common Cold, Dietary Supplements, Female, Garlic, Humans, Male, Middle Aged, Probability, Reference Values, Sulfinic Acids, Treatment Outcome","pages":"189–193","bibtex":"@article{josling_preventing_2001,\n\ttitle = {Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey},\n\tvolume = {18},\n\tissn = {0741-238X},\n\tshorttitle = {Preventing the common cold with a garlic supplement},\n\tdoi = {10.1007/BF02850113},\n\tabstract = {One hundred forty-six volunteers were randomized to receive a placebo or an allicin-containing garlic supplement, one capsule daily, over a 12-week period between November and February. They used a five-point scale to assess their health and recorded any common cold infections and symptoms in a daily diary. The active-treatment group had significantly fewer colds than the placebo group (24 vs 65, P {\\textless} .001). The placebo group, in contrast, recorded significantly more days challenged virally (366 vs 111, P {\\textless} .05) and a significantly longer duration of symptoms (5.01 vs 1.52 days, P {\\textless} .001). Consequently, volunteers in the active group were less likely to get a cold and recovered faster if infected. Volunteers taking placebo were much more likely to get more than one cold over the treatment period. An allicin-containing supplement can prevent attack by the common cold virus.},\n\tlanguage = {eng},\n\tnumber = {4},\n\tjournal = {Advances in Therapy},\n\tauthor = {Josling, P.},\n\tmonth = aug,\n\tyear = {2001},\n\tpmid = {11697022},\n\tkeywords = {Adult, Aged, Anti-Infective Agents, Common Cold, Dietary Supplements, Female, Garlic, Humans, Male, Middle Aged, Probability, Reference Values, Sulfinic Acids, Treatment Outcome},\n\tpages = {189--193},\n}\n\n","author_short":["Josling, P."],"key":"josling_preventing_2001","id":"josling_preventing_2001","bibbaseid":"josling-preventingthecommoncoldwithagarlicsupplementadoubleblindplacebocontrolledsurvey-2001","role":"author","urls":{},"keyword":["Adult","Aged","Anti-Infective Agents","Common Cold","Dietary Supplements","Female","Garlic","Humans","Male","Middle Aged","Probability","Reference Values","Sulfinic Acids","Treatment Outcome"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/zotero/ckelleyt","dataSources":["W5PhLT7vuF6ko8d7J","tTydwtpFKyvDpy8qn"],"keywords":["adult","aged","anti-infective agents","common cold","dietary supplements","female","garlic","humans","male","middle aged","probability","reference values","sulfinic acids","treatment outcome"],"search_terms":["preventing","common","cold","garlic","supplement","double","blind","placebo","controlled","survey","josling"],"title":"Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey","year":2001}